Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Pharmacological Research|June 20, 2018
Cysteinyl-leukotriene pathway as a new therapeutic target for the treatment of atherosclerosis related to obstructive sleep apnea syndromeElodie Gautier-Veyret, Magnus Bäck, Claire Arnaud, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2019
Treatment by Posaconazole Tablets, Compared to Posaconazole Suspension, Does Not Reduce Variability of Posaconazole Trough ConcentrationsElodie Gautier-Veyret, Léa Bolcato, Matthieu Roustit, et al.
Journal of Clinical Medicine|June 2, 2021
Combined Impact of Inflammation and Pharmacogenomic Variants on Voriconazole Trough Concentrations: A Meta-Analysis of Individual DataLéa Bolcato, Charles Khouri, Anette Veringa, et al.
The European Respiratory Journal|October 13, 2012
Intermittent hypoxia-activated cyclooxygenase pathway: role in atherosclerosisElodie Gautier-Veyret, Claire Arnaud, Magnus Bäck, et al.
British Journal of Clinical Pharmacology|March 15, 2023
Discrepancies between dihydropyrimidine dehydrogenase phenotyping and genotyping: What are the explanatory factors?Capucine Arrivé, Xavier Fonrose, Fabienne Thomas, et al.
Journal De Mycologie Medicale|January 10, 2025
Biliary diffusion and antifungal activity of caspofungin and fluconazole in liver transplant recipients: A pilot studyCécile Garnaud, Thibaut Gelé, Elodie Gautier-Veyret, et al.
Journal of Lipid Research|July 5, 2012
Leukotriene B4 pathway activation and atherosclerosis in obstructive sleep apneaFrançoise Stanke-Labesque, Jean-Louis Pépin, Tiphaine de Jouvencel, et al.
The Journal of Antimicrobial Chemotherapy|November 11, 2025
Evaluation of subcutaneous amoxicillin/clavulanic acid pharmacokinetics as an alternative to the intravenous route in older patients-the PhASAge StudyNicolas Grégoire, David Mbarga, Hélène Mirfendereski, et al.
Pageof 10